){kind=small}
Ventas (VTR) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Ventas (VTR) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Ventas (VTR) Matches Q4 FFO Estimates
Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.89 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.81 per share a year ago.
Ahead of Ventas (VTR) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Ventas (VTR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
What's in the Offing for Ventas Stock This Earnings Season?
VTR's Q4 earnings are expected to show solid revenue and FFO growth, driven by SHOP & OM&R portfolio strength despite weakness in triple-net leased properties.
Ventas Stock Gains 10.9% in Three Months: Will it Continue to Rise?
VTR shares are up 10.9% in three months, fueled by senior housing demand, outpatient trends, accretive investments and a stronger balance sheet.
Ventas, Inc. (NYSE:VTR) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Ventas, Inc. (NYSE: VTR - Get Free Report) have earned an average rating of "Moderate Buy" from the nineteen analysts that are currently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, fifteen have assigned a buy recommendation and one has issued a strong buy recommendation on
Ventas Has Recently Reached 52-Week Highs, Now What? (Technical Analysis)
Ventas, Inc. has surged 23% since July, recently hitting new 52-week highs and consolidating above its 30-week EMA. Despite overvaluation by fundamental metrics, VTR exhibits strong technical momentum, bullish volume, and institutional accumulation. Short- and long-term momentum readings are bullish, with the PPO indicator at 5.350 and volume supporting continued strength.
Ventas Is Hitting On All Cylinders
Ventas has evolved into a growth REIT, driven by strong SHOP portfolio execution and disciplined acquisitions below replacement cost. VTR delivered strong normalized FFO/share growth in Q3 2025, with management raising full-year FFO and NOI growth guidance on robust SHOP performance. Despite trading above historical P/FFO, VTR's premium is justified by accelerating FFO and NOI growth, demographic tailwinds, and a balanced risk/reward profile.
Ventas Stock Rallies 24.5% in Six Months: Will the Trend Last?
VTR shares rise 24.5% in six months, far outperforming the industry, as strong SHOP growth and balance sheet gains lift sentiment.
Key Reasons to Add Ventas Stock to Your Portfolio Right Now
VTR gains momentum as its healthcare real estate portfolio, research investments and solid balance sheet point to further growth potential.
Why Is Ventas (VTR) Up 7.7% Since Last Earnings Report?
Ventas (VTR) reported earnings 30 days ago. What's next for the stock?
Are You Looking for a Top Momentum Pick? Why Ventas (VTR) is a Great Choice
Does Ventas (VTR) have what it takes to be a top stock pick for momentum investors? Let's find out.
